Juniper Pharmaceuticals Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures decline as oil surge, high yields stoke inflation worries
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Goldman Sachs sees 18% upside for Palantir on sovereign AI growth
- Citi names 5 top chip picks ahead of Q3 earnings
- PepsiCo shares climb after Q3 beat, though company trims profit forecast
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Juniper Pharma (JNP) Misses Q2 EPS by 1c
August 4, 2015 7:15 AM EDTJuniper Pharma (NASDAQ: JNP) reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $7.8 million.
For earnings history and earnings-related data on Juniper Pharma (JNP) click here.
... More


